tirzepatide kidney damage Parameters with in Obesity... : Journal of the American Society of Nephrology SURPASS-CVOT: Tirzepatide Significantly Reduces Major
Description
If symptoms stay at the injection site and clear within a week, it is a local reaction
According to the Wegovy SmPC, clinicians should consider discontinuation if less than 5% body weight loss is achieved after approximately 3 months at the 2.4 mg maintenance dose
Consult your dentist or pharmacist for recommendations
Goals differ
Legal action is underway in the US, with lawyers alleging the weight loss drugmakers didnt properly warn users about the risks
